KMP showed inhibitory effects against aryl hydrocarbon receptor (AHR)- and nuclear factor erythroid 2-related factor 2 (Nrf2)-induced expression of the drug-metabolizing enzyme in hepatocellular carcinoma [68]. This evidence concerns the gene NFE2L2 and hepatocellular carcinoma.